Rapid Readouts: Phase 2 Study of Navitoclax in High-Risk Myelofibrosis - Episode 1

Phase 2 Study of Navitoclax in High-Risk Myelofibrosis

January 15, 2021

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Now Playing: Phase 2 Study of Navitoclax in High-Risk Myelofibrosis

    Sponsored by AbbVie

    x